Glioblastoma, IDH-wildtype
Clinical trials for Glioblastoma, IDH-wildtype explained in plain language.
Never miss a new study
Get alerted when new Glioblastoma, IDH-wildtype trials appear
Sign up with your email to follow new studies for Glioblastoma, IDH-wildtype, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Laser zaps brain tumor, then immunotherapy fights back: new hope for glioblastoma?
Disease control Not yet recruitingThis study tests a new approach for recurrent glioblastoma, an aggressive brain cancer. It combines a minimally invasive laser that heats and destroys tumor tissue (LiTT) with an immunotherapy drug called cemiplimab, which helps the immune system attack cancer cells. About 99 par…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Glowing dye could help surgeons spot hidden brain cancer
Disease control Not yet recruitingThis phase 2 trial tests a single dose of FG001, a fluorescent dye, in 76 adults with newly diagnosed high-grade glioma. The dye is given before surgery and glows under a special light, helping surgeons tell tumor from healthy tissue during removal. The study checks how well the …
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase 2 • Sponsor: FluoGuide A/S • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC